Product Information

TADALAFIL 20 MG TABLET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.1998 per EA under NDC 68382089910. Its NADAC has been published 60 times since Oct 1, 2025.

FDA first approved this application on Mar 26, 2019. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TADALAFIL 20 MG TABLET

Tadalafil
$0.1998per EA

Strength

20 mg/1

NDC

68382089910

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

TADALAFIL

Approval Type

Generic (ANDA)

FDA Application

ANDA206693

FDA Approved

3/26/2019

TE Code

AB1

On Market Since

3/27/2019

Pharmacological Classes

Phosphodiesterase 5 Inhibitor
Phosphodiesterase 5 Inhibitors

Price Statistics

The NADAC for TADALAFIL 20 MG TABLET has been published 60 times since Oct 1, 2025, and over the history we have for it it has declined 2.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1998 per EA
All-time high$0.2116 (Nov 12, 2025)
All-time low$0.1582 (Aug 19, 2026)
52-week high$0.2101
52-week low$0.1582
Median price$0.1894
Average price$0.1874
Largest weekly change+12.9% (Oct 21, 2026)
Weeks tracked60
Tracking sinceOct 1, 2025

Price History

1W

+5.9%

1M

+19.6%

3M

+26.3%

6M

+11.2%

1Y

-4.9%

3Y

N/A

5Y

N/A

All

-2.8%

Generic Alternatives

The matcher finds 18 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 28% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of TADALAFIL 20 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for TADALAFIL 20 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.1998 per EA (NDC 68382089910), effective Nov 18, 2026.

How has the price of TADALAFIL 20 MG TABLET changed over time?

Over the history we have for it, the NADAC for TADALAFIL 20 MG TABLET has declined 2.8%. It has been tracked across 60 weekly CMS publications since Oct 1, 2025.

What are the highest and lowest recorded NADAC prices for TADALAFIL 20 MG TABLET?

Since Oct 1, 2025, the NADAC for TADALAFIL 20 MG TABLET has ranged from a low of $0.1582 (Aug 19, 2026) to a high of $0.2116 (Nov 12, 2025), with a median of $0.1894 per EA.

Are there cheaper alternatives to TADALAFIL 20 MG TABLET?

Yes. 18 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TADALAFIL 20 MG TABLET, is $0.1439 per EA — about 28% below TADALAFIL 20 MG TABLET.

Who manufactures TADALAFIL 20 MG TABLET?

TADALAFIL 20 MG TABLET (NDC 68382089910) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.